Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines

Leukemia

Volumn 10, Issue 3, 1996, Pages 417-425

  Quillet Mary, A ^a   Mansat, V ^a   Duchayne, E ^a   Come, M G ^a   Allouche, M ^a   Bailly, J D ^a   Bordier, C ^a   Laurent, G ^a,b  

^a CHU PURPAN   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Apoptosis; Daunorubicin; Leukemia; Multidrug resistance; Oxidative balance

Indexed keywords

ANTIOXIDANT; DAUNORUBICIN; DNA FRAGMENT; GLYCOPROTEIN P; PYRROLIDINE DERIVATIVE; VERAPAMIL;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0029942653     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sinha BK, Mimnaugh EG. Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors. Free Radicals Biol Med 1990; 8: 567-581.
2. Baer MR, Bloomfield CD. Multidrug resistance in acute myeloid leukemia. J Natl Cancer Inst 1991; 83: 663-712.
3. Sachs L, Lotem J. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 1993; 82: 15-21.
4. Ling YH, Priebe W, Perez-Soler R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 1993; 53: 1845-1852.
5. Lotem J, Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 1992; 80: 1750-1757.
6. Gromova II, Thomsen B, Razin SV. Different topoisomerase N anti-tumor drugs direct similar specific long-range fragmentation of an amplified c-myc gene locus in living cells and in high-salt-extracted nuclei. Proc Natl Acad Sci USA 1995; 92: 102-106.
7. Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z. Induction of DNA strand breaks associated with apoptosis during treatment of leukemia. Leukemia 1993; 7: 659-670.
8. Peterson GL. A simplification of the protein assay method of Lowry et al which is generally more applicable. Anal Biochem 1977, 83: 346-356.
9. Mosmann T Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Meth 1983; 65: 55-63.
10. Bailly JD, Muller C, Jaffrézou JP, Demur C, Cassar G, Bordier C, Laurent G. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemic cells. Leukemia 1995; 9: 799-807.
11. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10.
12. Schreck R, Meier B, Männel D, Droge W, Baeurle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992; 175: 1181-1194.
13. Dusre L, Mimnaugh EG, Myers CE, Sinha BK. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. Cancer Res 1989; 49: 511-515.
14. Speth PAJ, Linssen PCM, Boezeman JBM, Wessels HMC, Haanen C. Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chemother Pharmacol 1987; 20: 311-315.
15. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other anticancer drugs: a cautionary note. Cancer Res 1989; 49: 5870-5878.
16. Solary E, Bertrand R, Kohn KW, Pommier Y. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 1993; 81: 1359-1368.
17. Kapunscinski J, Darzynkiewicz Z. Relationship between the pharmacological activity of antitumor drugs Ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids. Proc Natl Acad Sci USA 1986; 83: 6302-6306.
18. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993; 12: 3679-3684.
19. Chiron M, Demur C, Pierson V, Jaffrézou JP, Muller C, Saivin S, Bordier C, Bousquet C, Laurent C. Sensitivity of fresh acute myeloid leukemia cells to etoposide: relationship with cell growth characteristics and DNA cleavage. Blood 1992; 80: 209-216.
20. Lotem J, Sachs L. Regulation by bcl-2, c-myc, and p-53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ 1993; 4: 41-47.
21. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-251.
22. Kane DJ, Sarafian TA, Anton R, Hahn H, Butler Gralla E, Selverstone Valentine J, Ord T, Bredesen DE. Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species. Science 1993; 262: 1274-1277.
23. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzela F, Pierotti MA, Porta CD. bcl-2 proto-oncogen expression in normal and neoplastic human myeloid cells. Blood 1992; 79: 1291-1298.